<DOC>
	<DOCNO>NCT01847391</DOCNO>
	<brief_summary>This phase 1 , single-blind , randomize , placebo-controlled , multiple ascend dose study aim assess safety , tolerability , pharmacokinetics GS-6615 healthy subject .</brief_summary>
	<brief_title>A Phase 1 Study Assess Safety , Tolerability , Pharmacokinetics GS-6615 Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<criteria>Weight least 50 kg body mass index ( BMI ) 18 30 kg/m2 Female subject must nonchildbearing potential define per protocol Male subject female partner childbearing potential must use protocol acceptable method contraception Willing able comply requirement protocol direction Willing avoid consumption grapefruit , grapefruit juice Seville oranges Willing avoid consumption nicotine ( include nicotine gum ) alcoholic beverage Ongoing history medical surgical condition , judgment Investigator , might jeopardize subject 's safety interfere study objective History meningitis encephalitis , seizure , migraine , tremor , myoclonic jerk , sleep disorder , anxiety , syncope , head injury family history seizures Any abnormal ECG finding , abnormal laboratory value , physical examination finding Screening judge clinically significant Any abnormal neurological examination finding Screening judge clinically significant Hemoglobin &lt; 12 g/dL Serology test positive HIV , hepatitis B C Positive urine drug test ( include cotinine ethanol ) Use systemic prescription medication counter ( OTC ) medication , include multivitamin , dietary herbal supplement Use experimental investigational drug device within 30 day Female subject childbearing potential , pregnant lactate Donation loss blood within 8 week and/or donation plasma within 7 day History drug alcohol abuse Psychosocial addictive disorder</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>Ischemic Heart Disease</keyword>
	<keyword>Heart Disease</keyword>
</DOC>